Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Mates Sharon | Chairman and CEO | Apr 24 '24 | Option Exercise | 17.26 | 20,020 | 345,618 | 1,070,329 | Apr 25 05:08 PM | RIGGS RORY B | Director | Mar 20 '24 | Option Exercise | 18.56 | 20,000 | 371,200 | 99,235 | Mar 22 04:12 PM | Mates Sharon | Chairman, President & CEO | Mar 11 '24 | Sale | 65.21 | 20,565 | 1,341,123 | 1,050,309 | Mar 11 08:33 PM | Hineline Lawrence J. | SVP of Finance, CFO | Mar 11 '24 | Sale | 65.96 | 10,121 | 667,587 | 0 | Mar 11 08:33 PM | Halstead Michael | EVP and General Counsel | Mar 11 '24 | Sale | 65.97 | 7,345 | 484,537 | 0 | Mar 11 08:32 PM | Neumann Mark | EVP, Chief Commercial Officer | Mar 11 '24 | Sale | 65.61 | 7,345 | 481,931 | 29,700 | Mar 11 08:31 PM | Durgam Suresh K. | EVP, Chief Medical Officer | Mar 11 '24 | Sale | 65.59 | 3,712 | 243,482 | 19,803 | Mar 11 08:31 PM | Hineline Lawrence J. | SVP of Finance, CFO | Mar 10 '24 | Option Exercise | 56.73 | 4,539 | 257,497 | 4,539 | Mar 11 08:33 PM | Mates Sharon | Chairman, President & CEO | Mar 07 '24 | Sale | 66.50 | 40,712 | 2,707,277 | 1,050,309 | Mar 11 08:33 PM | Hineline Lawrence J. | SVP of Finance, CFO | Mar 07 '24 | Sale | 66.60 | 13,132 | 874,560 | 0 | Mar 11 08:33 PM | Neumann Mark | EVP, Chief Commercial Officer | Mar 07 '24 | Sale | 66.57 | 13,132 | 874,179 | 29,700 | Mar 11 08:31 PM | Halstead Michael | EVP and General Counsel | Mar 07 '24 | Sale | 66.15 | 13,132 | 868,698 | 0 | Mar 11 08:32 PM | Durgam Suresh K. | EVP, Chief Medical Officer | Mar 07 '24 | Sale | 66.56 | 6,450 | 429,308 | 16,170 | Mar 11 08:31 PM | VAN NOSTRAND ROBERT L | Director | Feb 27 '24 | Option Exercise | 18.56 | 20,000 | 371,200 | 29,611 | Feb 28 07:41 PM | VAN NOSTRAND ROBERT L | Director | Feb 27 '24 | Sale | 72.93 | 20,000 | 1,458,650 | 9,611 | Feb 28 07:41 PM | MARCUS JOEL S | Director | Feb 26 '24 | Option Exercise | 48.93 | 36,757 | 1,798,678 | 65,990 | Feb 27 07:57 PM | Hineline Lawrence J. | SVP of Finance, CFO | Feb 26 '24 | Option Exercise | 36.89 | 5,882 | 216,987 | 5,882 | Feb 27 08:00 PM | MARCUS JOEL S | Director | Feb 26 '24 | Sale | 68.68 | 26,328 | 1,808,253 | 39,662 | Feb 27 07:57 PM | Mates Sharon | Chairman, President & CEO | Feb 26 '24 | Sale | 69.79 | 22,590 | 1,576,464 | 1,050,309 | Feb 27 07:59 PM | Hineline Lawrence J. | SVP of Finance, CFO | Feb 26 '24 | Sale | 69.43 | 13,337 | 925,961 | 0 | Feb 27 08:00 PM | Neumann Mark | EVP, Chief Commercial Officer | Feb 26 '24 | Sale | 70.13 | 7,907 | 554,491 | 29,700 | Feb 27 07:58 PM | Halstead Michael | EVP and General Counsel | Feb 26 '24 | Sale | 69.53 | 7,907 | 549,784 | 0 | Feb 27 08:00 PM | Durgam Suresh K. | EVP, Chief Medical Officer | Feb 26 '24 | Sale | 70.17 | 4,112 | 288,534 | 9,488 | Feb 27 07:58 PM | Mates Sharon | Chairman, President & CEO | Feb 02 '24 | Sale | 67.07 | 33,885 | 2,272,694 | 1,050,309 | Feb 05 06:10 PM | Neumann Mark | EVP, Chief Commercial Officer | Feb 02 '24 | Sale | 67.15 | 11,860 | 796,367 | 29,700 | Feb 05 06:07 PM | Halstead Michael | EVP and General Counsel | Feb 02 '24 | Sale | 66.42 | 11,860 | 787,719 | 0 | Feb 05 06:13 PM | Hineline Lawrence J. | SVP of Finance, CFO | Feb 02 '24 | Sale | 66.62 | 11,183 | 745,037 | 0 | Feb 05 06:05 PM | Durgam Suresh K. | EVP, Chief Medical Officer | Feb 02 '24 | Sale | 67.19 | 6,167 | 414,355 | 5,693 | Feb 05 06:02 PM | Mates Sharon | Chairman, President & CEO | Jan 18 '24 | Option Exercise | 16.86 | 67,917 | 1,145,081 | 1,118,226 | Jan 18 07:47 PM | Mates Sharon | Chairman, President & CEO | Jan 18 '24 | Sale | 65.19 | 67,917 | 4,427,848 | 1,050,309 | Jan 18 07:47 PM | Mates Sharon | Chairman, President & CEO | Jan 17 '24 | Option Exercise | 16.86 | 48,084 | 810,696 | 1,098,393 | Jan 18 07:47 PM | Mates Sharon | Chairman, President & CEO | Jan 17 '24 | Sale | 66.24 | 48,084 | 3,185,062 | 1,050,309 | Jan 18 07:47 PM | Mates Sharon | Chairman, President & CEO | Jan 16 '24 | Option Exercise | 16.86 | 75,361 | 1,270,586 | 1,125,670 | Jan 18 07:47 PM | Mates Sharon | Chairman, President & CEO | Jan 16 '24 | Sale | 67.25 | 75,361 | 5,067,982 | 1,050,309 | Jan 18 07:47 PM | Halstead Michael | EVP and General Counsel | Jan 11 '24 | Option Exercise | 13.60 | 50,000 | 680,051 | 50,000 | Jan 12 06:02 PM | Halstead Michael | EVP and General Counsel | Jan 11 '24 | Sale | 66.83 | 50,000 | 3,341,699 | 0 | Jan 12 06:02 PM | Durgam Suresh K. | EVP, Chief Medical Officer | Jan 02 '24 | Option Exercise | 19.87 | 62,282 | 1,237,543 | 62,282 | Jan 04 07:54 PM | Durgam Suresh K. | EVP, Chief Medical Officer | Jan 02 '24 | Sale | 70.60 | 62,282 | 4,397,113 | 0 | Jan 04 07:54 PM | Durgam Suresh K. | EVP, Chief Medical Officer | Dec 13 '23 | Sale | 65.00 | 21,262 | 1,382,030 | 0 | Dec 15 05:01 PM | Neumann Mark | EVP, Chief Commercial Officer | Nov 06 '23 | Option Exercise | 23.94 | 26,754 | 640,491 | 72,093 | Nov 08 05:31 PM | Neumann Mark | EVP, Chief Commercial Officer | Nov 06 '23 | Sale | 55.63 | 42,393 | 2,358,152 | 29,700 | Nov 08 05:31 PM | Mates Sharon | Chairman, President & CEO | Sep 19 '23 | Sale | 54.17 | 44,413 | 2,405,852 | 1,050,309 | Sep 19 08:40 PM | Mates Sharon | Chairman, President & CEO | Sep 18 '23 | Sale | 53.76 | 55,587 | 2,988,213 | 1,094,722 | Sep 19 08:40 PM | Neumann Mark | EVP, Chief Commercial Officer | Aug 07 '23 | Option Exercise | 18.59 | 55,300 | 1,028,027 | 100,639 | Aug 09 06:05 PM | Neumann Mark | EVP, Chief Commercial Officer | Aug 07 '23 | Sale | 58.79 | 55,300 | 3,251,087 | 45,339 | Aug 09 06:05 PM | Durgam Suresh K. | EVP, Chief Medical Officer | Jul 17 '23 | Sale | 65.00 | 1,842 | 119,730 | 21,262 | Jul 20 05:47 PM | Hineline Lawrence J. | SVP of Finance CFO | Jun 14 '23 | Option Exercise | 42.30 | 81,854 | 3,462,317 | 81,854 | Jun 16 05:05 PM | Hineline Lawrence J. | SVP of Finance CFO | Jun 14 '23 | Sale | 63.97 | 81,854 | 5,236,329 | 0 | Jun 16 05:05 PM |
|